Anti-CAP1/PARK7抗體,CAP1抗體說明書產品詳細資料

產品編號 BYK-1306R

英文名稱 CAP1
中文名稱 CAP1抗體
別    名 PARK7; PARK-7; Parkinson disease protein 7; Park7 protein; CAP1; DJ-1; Dj1; DJ 1; SP22; Protein DJ-1; Oncogene DJ1; FLJ27376; Park 7; Parkinson disease (autosomal recessive early onset) 7; RNA binding protein regulatory subunit; RS; SP22; CAP1_HUMAN.
研究領域 腫瘤  免疫學  神經生物學  信號轉導  激酶和磷酸酶  表觀遺傳學  G蛋白信號  
分 子 量 20kDa
細胞定位 細胞核 細胞漿 

抗體來源 Mouse or Rabbit
克隆類型 Monoclonal or Polyclonal
產品應用 WB、ELISA、IHC-P、IHC-F、Flow-Cyt、IF、IP、ICC 此產品應用不做依據，具體產品應用與實驗稀釋比請！

not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.

性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
亞    型 IgG
純化方法 affinity purified by Protein G
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.


     Anti-CAP1/PARK7抗體,CAP1抗體說明書產品介紹 

      PARK7/DJ1 is a ubiquitously expressed protein involved in various cellular processes including cell proliferation, RNA-binding, and oxidative stress. The protein has been found to colocalize within a subset of pathologic tau inclusions in a diverse group of neurodegenerative disorders known as tauopathies (Rizzu et al. 2004). Defects in PARK7/DJ1 are the cause of autosomal recessive early-onset Parkinson's disease 7 (PARK7). Parkinson's disease (PD) is a complex, multifactorial disorder that typically manifests after the age of 50 years. The disease is characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK7 is characterized by onset before 40 years and slow progression. It has also been suggested that PARK7/DJ1 is a mitogen dependent oncogene product involved in Ras related signal transduction pathways.

 此相關標記有：Alexa Fluor 350 標記、Alexa Fluor 488 標記、Alexa Fluor 555 標記、Alexa Fluor 647 標記、AP標記、APC標記、Biotin標記、Cy3標記、Cy5標記、Cy5.5標記、Cy7標記、FITC標記、Gold標記、HRP標記、PE標記、PE-Cy3標記、PE-CY5標記、PE-CY5.5標記、PE-CY7標記、RBITC標記 

     相關產品：

     Anti-GRAP抗體,生長因子受體結合蛋白2相關接頭蛋白抗體

Anti-GRB 14抗體,生長因子受體結合蛋白14抗體
Anti-GAL4抗體,調節蛋白GAL4抗體
Anti-GRO Alpha抗體,黑色素瘤刺激活性蛋白α抗體
Anti-GLUT2抗體,葡萄糖轉運蛋白2抗體
Anti-GADD34抗體,生長抑制DNA損傷基因34抗體
Anti-Galectin-1抗體,半乳糖凝集素1抗體
Anti-GRP抗體,半乳糖凝集素相關蛋白GRP抗體
Anti-Gastrokine 1抗體,胃竇粘膜蛋白GKN1抗體
Anti-GA2L2抗體,GA2L2蛋白抗體
Anti-GABARAPL3抗體,γ氨基丁酸受體相關蛋白樣3抗體
Anti-GABRR3抗體,G氨基丁酸A型受體rho3/GABAc Rρ3抗體
Anti-GAGE1抗體,GAGE1蛋白抗體
Anti-GAGE12H抗體,GAGE12H蛋白抗體
Anti-GAGE2A抗體,GAGE2A蛋白抗體
Anti-GAGE6抗體,GAGE6蛋白抗體
Anti-GAK抗體,細胞周期蛋白G相關激酶抗體
Anti-GAL3ST1抗體,半乳糖神經酰胺磺基轉移酶抗體
Anti-GAL3ST2抗體,半乳糖神經酰胺磺基轉移酶2抗體
Anti-GAL3ST4抗體,GAL3ST4蛋白抗體